Finally, and rather interestingly, liraglutide as an adjunct to insulin has been shown to improve glycaemic control, induce body weight loss and decrease exogenous insulin requirements and severe hypoglycaemia in patients with type 1 diabetes mellitus [82]. The gene discussed is INS; the disease is type 1 diabetes mellitus.